Traws Pharma, Inc.
TRAW
$1.88
$0.021.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.82M | -140.05M | -166.52M | -140.79M | -137.05M |
| Total Depreciation and Amortization | 6.00K | 9.00K | 12.00K | 14.00K | 17.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.28M | 116.61M | 143.29M | 118.85M | 118.87M |
| Change in Net Operating Assets | -7.84M | -7.37M | -6.57M | -8.26M | -5.01M |
| Cash from Operations | -26.93M | -30.81M | -29.79M | -30.18M | -23.18M |
| Capital Expenditure | -- | -- | -- | 0.00 | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -3.65M | -3.65M | -3.65M | -3.65M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -3.65M | -3.65M | -3.65M | -3.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23.37M | 34.11M | 33.98M | 14.00M | 14.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -287.00K | -123.00K | -- | -- | -- |
| Cash from Financing | 23.09M | 33.99M | 33.98M | 14.00M | 14.00M |
| Foreign Exchange rate Adjustments | 42.00K | 11.00K | -19.00K | -3.00K | -5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.81M | -453.00K | 517.00K | -19.83M | -12.84M |